Lazard Asset Management’s Viking Therapeutics VKTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-12,801
Closed -$207K 2494
2023
Q2
$207K Buy
+12,801
New +$207K ﹤0.01% 1335